Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Meningioma × Dexmedetomidine × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 19 Breast Neoplasms 13 Brain Neoplasms 11 Agnosia 7 Neoplasms 6 Lung Neoplasms 5 Delirium 5 Thyroid Neoplasms 4 Stomach Neoplasms 4 Pituitary Neoplasms 3 Pain 3 Inflammation 3 Emergence Delirium 3 Colorectal Neoplasms 3 Chronic Pain 3 Urinary Bladder Neoplasms 2 Supratentorial Neoplasms 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Pheochromocytoma 2 Pain, Intractable 2 Neoplasm Metastasis 2 Liver Neoplasms 2 Dexmedetomidine 2 Colonic Neoplasms 2 Central Nervous System Diseases 2 Abdominal Neoplasms 2 Thrombosis 1 Spinal Cord Neoplasms 1 Sleep Initiation and Maintenance Disorders 1

Interventions

Magnetic Resonance Spectroscopy 16 Hydroxyurea 7 Everolimus 7 lutetium Lu 177 dotatate 6 gallium Ga 68 dotatate 6 Radiosurgery 6 Proton Therapy 6 Bevacizumab 6 Specimen Handling 5 pembrolizumab 4 Surveys and Questionnaires 4 Surgical Procedures, Operative 4 Radiotherapy 4 Imatinib Mesylate 4 Cyclophosphamide 4 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 4 aldesleukin 3 abemaciclib 3 Tranexamic Acid 3 Temozolomide 3 Sunitinib 3 Sodium Chloride 3 Radiotherapy, Intensity-Modulated 3 Observation 3 Nivolumab 3 Ga(III)-DOTATOC 3 90Y-octreotide, DOTA-Tyr(3)- 3 vistusertib 2 trametinib 2 ribociclib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07398066 2026-02-09

DEX-NEURO

University of Malaya

Phase NA Not yet recruiting

Brain Neoplasms, Delirium, Meningioma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡